Jane: Mother of Morphea Scleroderma Patient |
|||||||||
| I was happy to learn that morphea usually does not recur, and that it does not progress into systemic scleroderma. |
|||||||||
I immediately searched for any information I could find, but to no avail. There was very little information back then, even in the library. The doctor explained that it was a disease in white women usually between the ages of thirty-five and fifty. He described systemic scleroderma with the tightening of the skin which usually began with the hands and then moved on to other parts of the body with the organs coming last. The ultimate prognosis: death. We were horrified but told not to worry. Not all cases are extreme and because Jenny was so young, she would probably have a better chance. The only correlation we found was a tick bite Jenny had received three weeks before the first appearance of morphea. She was on an Indian Princess campout with her father, and although he pulled the tick out of her back (right side), the tick's head remained. We eventually prayed over Jenny with our minister asking for healing and that the morphea would stop. And it did. My daughter is now fifteen, still bright, but has been left with some permanent, brown scarring on her leg, foot, and back. Our doctor recently gave her some bleaching cream to try to restore some of the color, because it is visible when Jenny wears a bathing suit. She has forgotten a lot about the morphea, but I have not. About the same time Jenny was diagnosed with morphea, she began to lose some of her hearing. She now has fifty percent loss in one ear and a thirty-five percent loss in the other. I cannot help but wonder if there is some correlation. Is hearing loss associated with morphea? Her hearing specialist has asked this question because we cannot find any other cause. She had perfect hearing prior to age six and no traumas. I am particularly concerned with the reoccurrence of morphea, or the possibility of systemic scleroderma. I was happy to learn that morphea usually does not recur, and that it does not progress into systemic scleroderma. |
|||||||||
| To Contact the Author | |||||||||
|

